The Role of Unilateral Intravitreal Bevacizumab (Avastin), for the Treatment of Bilateral Diabetic Macular Edema: a Pilot Study.
Phase of Trial: Phase IV
Latest Information Update: 17 Oct 2007
At a glance
- Drugs Bevacizumab (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 17 Oct 2007 Status change from recruting to completed.
- 06 Aug 2007 New trial record.